- Venture Capital Investment Trends in Pharma Q2 2025 | 115 Investors Back 53 Oncology Deals in Q2 2025's Pharma Sector
- Angitia Biopharmaceuticals to Present Data on AGA2115 for Osteogenesis Imperfecta at ASBMR 2025
- BioNTX Announces 2025 Tech Transfer Showcase Finalists Pitch Competition at the 2025 iC³® Life Science & Healthcare Innovation Summit
- Extrovis AG and Dr. Reddy’s announce the launch of the authorized generic of CARAC (fluorouracil cream), 0.5% in the U.S.
- Abstrax Ranks #1,549 on 2025 Inc. 5000 List, Reinforcing Its Trajectory as a Leading Flavor House
- Plant Biotechnology Company Evaluation Report 2025 | Bayer, Syngenta, and BASF Lead with Advanced Crop Protection, Seeds, and Sustainable Farming Solutions
- Evoke Pharma Reports Second Quarter 2025 Financial Results and Provides Business Update
- Hatteras Venture Partners Raises Over $200 Million in Capital Across Two Healthcare-Focused Funds
- [Latest] Global AI in Synthetic Biology Market Size/Share Worth USD 192.95 Billion by 2034 at a 28.63% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
- AEON Biopharma Reports Second Quarter 2025 Financial Results and Provides Corporate Update
